Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-018-0710-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC